Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Frontiers in Immunology|June 13, 2022
Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure ApproachesJose A Moran, Shireen R Turner, Matthew D MarsdenVirology|February 26, 2023
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversalJose A Moran, Alok Ranjan, Rami Hourani, et al.Retrovirology|April 8, 2020
Benefits and limitations of humanized mice in HIV persistence studiesMatthew D MarsdenScience Advances|January 24, 2025
Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIVZachary O Gentry, Owen D McAteer, Jennifer L Hamad, et al.Pathogens & Immunity|May 20, 2024
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer CellsMelanie Dimapasoc, Jose A Moran, Steve W Cole, et al.Bioorganic & Medicinal Chemistry Letters|June 6, 2013
HIV/AIDS eradicationMatthew D Marsden, Jerome A ZackFuture Virology|February 15, 2011
Establishment and maintenance of HIV latency: model systems and opportunities for interventionMatthew D Marsden, Jerome A ZackJournal of Virology|March 30, 2007
Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivoMatthew D Marsden, Jerome A ZackVirology|February 15, 2015
Studies of retroviral infection in humanized miceMatthew D Marsden, Jerome A ZackPageof 6